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ABSTRACT 
BACKGROUND:  
Cervical cancer is the second most common in women and the leading 
cause of cancer mortality in women in developing countries. 
Cervical cancer screening by Pap smear can diagnose preneoplastic and 
neoplastic lesions of cervical cancer which can be easily and effectively treated.  
Though Pap smear is the most frequently employed test in mass screening 
programs, it is always not feasible, it requires trained technicians, cytologists 
and good laboratories for mass screening.  Colposcopy and colposcopic biopsy 
are adequate, safe and sufficient techniques for the diagnosis of premalignant 
and malignant lesion of the carcinoma cervix but requires extensive training and 
experience.  Micronucleus assay is a rapid and reliable technique which can 
detect genetic instabilities and contribute to cancer screening methods.  
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1. To study the  presence of micronucleus in urothelial cells of patients 
with abnormal colposcopy ; 
2.To correlate with their colposcopic and histopathological findings. 
 
MATERIALS AND METHODS:: 
This is a one year prospective study conducted in Institute of Obstetrics 
and Gynecology, Madras Medical College.  50 VIA/VILI negative and 58 
VIA/VILI positive patients were randomly selected. A midstream urine sample  
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of 5ml is collected in aseptic vials of  these 108 patients attending colposcopic 
clinic.  These are processed within 3 to 4 hours of sample collection.  The 
samples are washed in phosphate buffered saline with alternate centrifugations 
at 1200 rpm for 10 minutes.  The pellets are smeared over the precleaned glass 
slides.  The slides are air dried and kept in the fixative of methanol for 20 
minutes.  The slides are stained with May Graunwald’s and Giemsa  stain 
and mounted in DPX.  The stained and washed slides are observed for nuclear 
abnormalities under bright field Olympus microscope and observations 
recorded.  VIA/VILI positive patients were subjected to cervical biopsy and 
sent for histopathological examinations.  The micronuclei assay is correlated 
with their colposcopic and histopathological findings. 
 
RESULTS: 
The sensitivity of micronuclei assay was 82.76% and sensitivity was 90%. 
The assay correlated with the colposcopic and histopathological findings 
and it was found to be statistically significant. 
 
CONCLUSION: 
Thus micronuclei assay can be used as a simple, reliable and cost effective 
screening test in detecting precursor lesions at the earliest. 
